Business Context and Reporting Period
This Form 8-K is a current report filed by Imprimis Pharmaceuticals, Inc. on October 17, 2014. The registrant is incorporated in Delaware and maintains its principal executive offices in San Diego, California. The filing serves to disclose Regulation FD information and provide access to management presentations.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report is a disclosure of presentations rather than a financial statement.
Material Changes
No material changes to financial performance or operations are reported in the text of this filing. The document solely references the attachment of two presentations used by management in meetings.
Guidance, Outlook, and Risks
Regulation FD Disclosure: The company attached two exhibits (99.1 and 99.2) containing presentations dated October 2014. These materials describe the company and are used in management meetings.
Legal Status of Exhibits: The information contained in these exhibits is explicitly not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and is not incorporated by reference into other filings unless expressly stated.
Key Facts for Investor Verification
- Verify the content of Exhibit 99.1 (Presentation dated October 2014) and Exhibit 99.2 (Corporate overview presentation dated October 2014) for specific business updates.
- Note that the attached presentations are not legally "filed" documents and do not carry the same liability protections as standard SEC filings.
- Confirm the company name discrepancy: The request metadata lists "HARROW, INC.", but the filing text clearly identifies the registrant as Imprimis Pharmaceuticals, Inc.